��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Cost-Effectiveness of Injectable Disease-Modifying Therapies in the Treatment of Multiple Sclerosis

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 040

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
	No disclosure on file
John D. Hixson, MD (Neurona Therapeutics)	Dr. Hixson has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Hixson has received personal compensation for serving as an employee of Nile Ai. Dr. Hixson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NextSense Inc.. Dr. Hixson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seer Medical. Dr. Hixson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Expert Institute. Dr. Hixson has received personal compensation in the range of $5,000-$9,999 for serving as a Reviewer with Epilepsy Study Consortium.
Srikant Rangaraju, MBBS (Emory University, Atlanta)	Dr. Rangaraju has nothing to disclose.
Carole Dembek (Biogen Idec)	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file